Product information
| Price | €175, €275, €395 |
|---|---|
| Size | 20 µl/µg | 50 µl/µg | 100 µl/µg |
| Short name | TSSC3 Antibody |
| Host | Rabbit |
| Isotype | IgG |
| Target protein | PHLDA2 |
| Recommended applications | ELISA, IHC-p |
| Reactivity | Human |
| Immunogen | The antiserum was produced against synthesized peptide derived from human PHLDA2. AA range:81-130 |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Formulation | Liquid in PBS containing 50% glycerol; 0.5% BSA and 0.02% sodium azide. |
| Storage | -20°C for 1 year |
| Product code | MB-AP13874 |
Additional information
Prev
Next
PHLDA2 (pleckstrin homology like domain family A member 2) is located in a cluster of imprinted genes on chromosome 11p15. , which is considered to be an important tumor suppressor gene region. Alterations in this region may be associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. PHLDA2 has been shown to be imprinted, with preferential expression from the maternal allele in placenta and liver.
PHLDA2, BWR1C, HLDA2, IPL, TSSC3, Pleckstrin homology-like domain family A member 2, Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein, Imprinted in placenta and liver protein,
Human: Q53GA4, Mouse: O08969
Human: 7262
